IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma

PURPOSE: Strategies for Indolamine-2,3-dioxygenase 1 (IDO1) inhibition in cancer immunotherapy once produced encouraging results, but failed in clinical trials. Recent evidence indicates that immune cells in the tumour microenvironment, especially macrophages, contribute to immune dysregulation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Struckmeier, Ann-Kristin, Radermacher, Anne, Fehrenz, Michael, Bellin, Tamara, Alansary, Dalia, Wartenberg, Philipp, Boehm, Ulrich, Wagner, Mathias, Scheller, Anja, Hess, Jochen, Moratin, Julius, Freudlsperger, Christian, Hoffmann, Jürgen, Thurner, Lorenz, Roemer, Klaus, Freier, Kolja, Horn, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314853/
https://www.ncbi.nlm.nih.gov/pubmed/35963900
http://dx.doi.org/10.1007/s00432-022-04277-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314853/
https://www.ncbi.nlm.nih.gov/pubmed/35963900
http://dx.doi.org/10.1007/s00432-022-04277-7

Ejemplares similares